| Name | tert-butyl 3-oxo-2-phenyl-3a,4,6,7-tetrahydropyrazolo[4,3-c]pyridine-5-carboxylate |
|---|---|
| Synonyms |
1-(toluene-4-sulfonyl)-1H-pyrrolo[2,3-b]pyridine-4-carbonitrile
4-cyano-1-(toluene-4-sulfonyl)-1H-pyrrolo[2,3-b]pyridine 5-Boc-3-oxo-2-phenyl-2,3,3a,4,6,7-hexahydropyrazolo[4,3-c]pyridine |
| Density | 1.35g/cm3 |
|---|---|
| Boiling Point | 471.797ºC at 760 mmHg |
| Molecular Formula | C15H11N3O2S |
| Molecular Weight | 297.33200 |
| Flash Point | 239.134ºC |
| Exact Mass | 297.05700 |
| PSA | 84.13000 |
| LogP | 3.53418 |
| Index of Refraction | 1.672 |
| HS Code | 2933990090 |
|---|
|
~%
348640-92-6 |
| Literature: Aventis Pharma S.A. Patent: US2007/93480 A1, 2007 ; Location in patent: Page/Page column 67-68 ; |
| Precursor 2 | |
|---|---|
| DownStream 0 | |
| HS Code | 2933990090 |
|---|---|
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |